p53 codon 72 polymorphism and rheumatoid arthritis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective. To investigate whether the p53 codon 72 polymorphism is associated with susceptibility to rheumatoid arthritis (RA) and its clinical features. Methods. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 114 patients with RA and 114 healthy controls. Clinical/serological manifestations were analyzed in each patient and correlated with the genotypes. Results. The genotype distribution of the p53 codon 72 did not differ between patients with RA and controls (Arg/Arg, Arg/Pro, Pro/Pro genotypes 38, 58, 18 vs 37, 60, 17 controls, respectively; chisquare = 0.08, 2 df, p = 0.96). No significant difference was found in allele frequencies between the groups. Clinically there was no significant difference in age at onset, functional class, physician's global assessment, ESR, CRP, RF titer, extraarticular and cervical spine involvement, frequencies of joint operation, and admission in RA patients according to the p53 codon 72 genotypes. However, the number of patients within each group was extremely small, for example only 5 patients with cervical spine involvement. No firm conclusions could safely be reached about clinical manifestations from this study. Conclusion. No association was found between the p53 codon 72 polymorphism and RA. Studies are needed to clarify the role of the p53 polymorphism in the pathogenesis of RA.

Original languageEnglish
Pages (from-to)2392-2394
Number of pages3
JournalJournal of Rheumatology
Volume28
Issue number11
Publication statusPublished - 2001 Nov 15

Fingerprint

Codon
Rheumatoid Arthritis
Genotype
Spine
Age of Onset
Gene Frequency
Restriction Fragment Length Polymorphisms
Physicians
Polymerase Chain Reaction
DNA

Keywords

  • p53 polymorphism
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

p53 codon 72 polymorphism and rheumatoid arthritis. / Lee, Young Ho; Kim, Y. R.; Ji, Jong Dae; Sohn, Jeongwon; Song, Gwan Gyu.

In: Journal of Rheumatology, Vol. 28, No. 11, 15.11.2001, p. 2392-2394.

Research output: Contribution to journalArticle

@article{c5ada8a02c2a4f6da814f2a53919b6b8,
title = "p53 codon 72 polymorphism and rheumatoid arthritis",
abstract = "Objective. To investigate whether the p53 codon 72 polymorphism is associated with susceptibility to rheumatoid arthritis (RA) and its clinical features. Methods. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 114 patients with RA and 114 healthy controls. Clinical/serological manifestations were analyzed in each patient and correlated with the genotypes. Results. The genotype distribution of the p53 codon 72 did not differ between patients with RA and controls (Arg/Arg, Arg/Pro, Pro/Pro genotypes 38, 58, 18 vs 37, 60, 17 controls, respectively; chisquare = 0.08, 2 df, p = 0.96). No significant difference was found in allele frequencies between the groups. Clinically there was no significant difference in age at onset, functional class, physician's global assessment, ESR, CRP, RF titer, extraarticular and cervical spine involvement, frequencies of joint operation, and admission in RA patients according to the p53 codon 72 genotypes. However, the number of patients within each group was extremely small, for example only 5 patients with cervical spine involvement. No firm conclusions could safely be reached about clinical manifestations from this study. Conclusion. No association was found between the p53 codon 72 polymorphism and RA. Studies are needed to clarify the role of the p53 polymorphism in the pathogenesis of RA.",
keywords = "p53 polymorphism, Rheumatoid arthritis",
author = "Lee, {Young Ho} and Kim, {Y. R.} and Ji, {Jong Dae} and Jeongwon Sohn and Song, {Gwan Gyu}",
year = "2001",
month = "11",
day = "15",
language = "English",
volume = "28",
pages = "2392--2394",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "11",

}

TY - JOUR

T1 - p53 codon 72 polymorphism and rheumatoid arthritis

AU - Lee, Young Ho

AU - Kim, Y. R.

AU - Ji, Jong Dae

AU - Sohn, Jeongwon

AU - Song, Gwan Gyu

PY - 2001/11/15

Y1 - 2001/11/15

N2 - Objective. To investigate whether the p53 codon 72 polymorphism is associated with susceptibility to rheumatoid arthritis (RA) and its clinical features. Methods. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 114 patients with RA and 114 healthy controls. Clinical/serological manifestations were analyzed in each patient and correlated with the genotypes. Results. The genotype distribution of the p53 codon 72 did not differ between patients with RA and controls (Arg/Arg, Arg/Pro, Pro/Pro genotypes 38, 58, 18 vs 37, 60, 17 controls, respectively; chisquare = 0.08, 2 df, p = 0.96). No significant difference was found in allele frequencies between the groups. Clinically there was no significant difference in age at onset, functional class, physician's global assessment, ESR, CRP, RF titer, extraarticular and cervical spine involvement, frequencies of joint operation, and admission in RA patients according to the p53 codon 72 genotypes. However, the number of patients within each group was extremely small, for example only 5 patients with cervical spine involvement. No firm conclusions could safely be reached about clinical manifestations from this study. Conclusion. No association was found between the p53 codon 72 polymorphism and RA. Studies are needed to clarify the role of the p53 polymorphism in the pathogenesis of RA.

AB - Objective. To investigate whether the p53 codon 72 polymorphism is associated with susceptibility to rheumatoid arthritis (RA) and its clinical features. Methods. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 114 patients with RA and 114 healthy controls. Clinical/serological manifestations were analyzed in each patient and correlated with the genotypes. Results. The genotype distribution of the p53 codon 72 did not differ between patients with RA and controls (Arg/Arg, Arg/Pro, Pro/Pro genotypes 38, 58, 18 vs 37, 60, 17 controls, respectively; chisquare = 0.08, 2 df, p = 0.96). No significant difference was found in allele frequencies between the groups. Clinically there was no significant difference in age at onset, functional class, physician's global assessment, ESR, CRP, RF titer, extraarticular and cervical spine involvement, frequencies of joint operation, and admission in RA patients according to the p53 codon 72 genotypes. However, the number of patients within each group was extremely small, for example only 5 patients with cervical spine involvement. No firm conclusions could safely be reached about clinical manifestations from this study. Conclusion. No association was found between the p53 codon 72 polymorphism and RA. Studies are needed to clarify the role of the p53 polymorphism in the pathogenesis of RA.

KW - p53 polymorphism

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0034766760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034766760&partnerID=8YFLogxK

M3 - Article

C2 - 11708408

AN - SCOPUS:0034766760

VL - 28

SP - 2392

EP - 2394

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 11

ER -